This article exists as part of the online archive for HuffPost Canada, which closed in 2021.

Ebola Outbreak: Canada Can Do More, Liberian Ambassador Says

CBC News is dedicating a special day of coverage to the Ebola crisis on Tuesday. On radio, television and online, we'll explore the facts behind Ebola and answer questions. Be part of the conversation Tuesday by using #ebolafacts on social media or by joining our live chat on starting at 8 p.m. ET.

Liberia's ambassador to Canada is asking the Canadian government to step up its response to the Ebola outbreak by sending more health-care workers, medical supplies, as well as the experimental drug to West Africa.

"We appreciate what the Government of Canada has done, but we will be asking them to do a little more than that," Ambassador Jeremiah Sulunteh told the crowd at a fundraising march for the global Ebola relief effort in Hamilton Saturday morning.

"We know they have the resources. We know they have the technology. We know they have the capability, the man power."

More specifically, Canada can help by sending doctors and nurses to Liberia to train local health-care workers, Sulunteh said. Donations of ambulances, hospital beds and medical supplies are also needed.

Sulunteh's visit to Hamilton comes a day after Canada's Health Minister Rona Ambrose announced another $30 million in aid to the United Nations mission to fight the Ebola outbreak.

The latest round of funding is on top of the $35 million Canada has previously pledged. However, only about $5 million of the $35 million has been spent so far.

Suluteh said the renewed commitment is "very much appreciated," but "a country such as Canada can do more than that."

'Use it on us'

Another way Canada can help is to send more doses of the experimental drug ZMapp currently in Winnipeg to West Africa, Suluteh added.

"What are they waiting for? It's about time to utilize that," he said.

The Canadian government plans to ship 800 to 1,000 vials of the drug to the WHO in Geneva on Monday, CBC News reported. Once there, clinical trials would begin to late October or early November to determine if it is safe to be used by humans.

The drug, developed through a collaboration between the Public Health Agency of Canada and U.S researchers, had never been tested on humans before it was given to two American health-care workers who were infected with Ebola in Liberia. They both survived.

Doctors, however, have said there is no way to know whether ZMapp helped with the recovery or patients recovered on their own. So far, about 45 per cent of people infected in the West African outbreak have recovered without treatment.

When asked about the uncertainty of the effects of the drug, Suluteh said the Liberian people have no other alternatives.

"Even if it would be the guinea pig, use it on us," he said.

Solunteh joined dozens of Hamiltonian, many of them from the local Liberian community, and marched from St. Joseph's Healthcare Hamilton to the YMCA.

The march is organized the local Liberian community association in partnership with Key-Action Network, a non-profit organization that provides settlement and integration support for new immigrants. It is followed by a fundraising dinner Saturday night.

Organizers say they hope to raise $20,000 worth of donations toward purchasing medical supplies and send them to Liberia in December.

Also on HuffPost

Ebola virus myth-busting

Suggest a correction
This article exists as part of the online archive for HuffPost Canada. Certain site features have been disabled. If you have questions or concerns, please check our FAQ or contact